Manufacturer:
Lilly
Route of Administration:
Intravenous, Subcutaneous
Site of Care:
Outpatient
Website:
Approved Indication:
- treatment of moderately to severely active Crohn’s disease in adults
- treatment of moderately to severely active ulcerative colitis in adults
Conditions:
- Crohn’s Disease
- Ulcerative Colitis
Therapeutic Area:
- Dermatology
- Gastroenterology
- Rheumatology